Immune phenotyping of diverse syngeneic murine brain tumors identifies immunologically distinct types
Jasneet Kaur Khalsa(Brigham and Women's Hospital), Khalid Shah(Harvard University)
Cited by 159
Related Papers
Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy
|Proceedings of the National Academy of Sciences|2009|454
MicroRNA-21 Knockdown Disrupts Glioma Growth <i>In vivo</i> and Displays Synergistic Cytotoxicity with Neural Precursor Cell–Delivered S-TRAIL in Human Gliomas
|Cancer Research|2007|407
Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression
|Cancer Discovery|2014|251
Genetic events associated with venetoclax resistance in CLL identified by whole-exome sequencing of patient samples
|Blood|2023|26
Systemic reprogramming of tumour immunity via IL-10-mRNA nanoparticles
|Nature Nanotechnology|2025|21